Stephens Consulting’s AMN Healthcare AMN Stock Holding History

Stephens Consulting’s Portfolio AMN Stock Details AMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-15	Closed	-$367	–	1228
2025 Q1	$367	Buy	+15	New	+$385	﹤0.01%	1219

Other funds holding AMN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stephens Consulting's AMN Position: Q2 2025 in Review

Stephens Consulting sold out of AMN Healthcare (AMN) in Q2 2025, closing a stake of 15 shares — an estimated $367 sold.

Stephens Consulting first reported a position in AMN in Q1 2025 and held it in 1 quarter. The position peaked at $367 in Q1 2025. 248 funds tracked by Wall St. Rank hold AMN as of Q2 2025.

Stephens Consulting reported no remaining AMN Healthcare position as of Q2 2025 after selling out during the quarter.
Stephens Consulting sold 15 AMN Healthcare shares in Q2 2025, an estimated $367.
Stephens Consulting first reported a position in AMN Healthcare in Q1 2025 and held it in 1 quarter.
Stephens Consulting's AMN Healthcare position peaked at $367 in Q1 2025.
248 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2025.

Based on Stephens Consulting's 13F filing for Q2 2025, filed 25 Jul 2025.